Tribute Pharmaceuticals Canada Inc. — key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2014)

CA$16.9M

Net Income/Loss (FY2014)

-$5.6M

Total Assets (FY2014)

CA$53.1M

Total Equity (FY2014)

$30.3M

Cash Flows from Operating Activities (FY2014)

-CA$1.9M

Source: Tribute Pharmaceuticals Canada Inc. 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.